-
1.
公开(公告)号:US20150205363A1
公开(公告)日:2015-07-23
申请号:US14424544
申请日:2012-08-30
Applicant: Lin-Na Wu
Inventor: Lin-Na Wu
CPC classification number: G06F3/017 , G02B13/0015 , G06T7/00 , H04N5/2257 , H04N5/232 , H04N5/23219 , H04N5/262
Abstract: A method of operating a device having at least two camera lenses includes inputting a first image via a first camera lens, and detecting a control gesture from image processing of the first image. The method further includes controlling an operation associated with processing an image input from a second camera lens in response to the detected gesture from the first image.
Abstract translation: 操作具有至少两个相机透镜的装置的方法包括经由第一相机透镜输入第一图像,以及从第一图像的图像处理检测控制手势。 该方法还包括响应于来自第一图像的检测到的手势,控制与从第二相机镜头输入的图像相关联的操作。
-
公开(公告)号:US09720508B2
公开(公告)日:2017-08-01
申请号:US14424544
申请日:2012-08-30
Applicant: Lin-Na Wu
Inventor: Lin-Na Wu
CPC classification number: G06F3/017 , G02B13/0015 , G06T7/00 , H04N5/2257 , H04N5/232 , H04N5/23219 , H04N5/262
Abstract: A method of operating a device having at least two camera lenses includes inputting a first image via a first camera lens, and detecting a control gesture from image processing of the first image. The method further includes controlling an operation associated with processing an image input from a second camera lens in response to the detected gesture from the first image.
-
公开(公告)号:US07053047B2
公开(公告)日:2006-05-30
申请号:US10404124
申请日:2003-04-02
Applicant: Shigi Peng , Ming Zhao , Chao Wang , Lin Na
Inventor: Shigi Peng , Ming Zhao , Chao Wang , Lin Na
Abstract: This invention relates to cyclic peptides, with the following formula (I) (SEQ ID NO: 1), cyclo(Xaa-Arg-Pro-Ala-Lys) (I) where Xaa is Ala, Gly, Glu, Gln, Asp, Asn, Arg or Lys. The cyclic peptides have thrombolytic effects. This invention also relates to cyclic peptide preparations.
Abstract translation: 本发明涉及具有下式(I)(SEQ ID NO:1),<?在线公式描述=“在线公式”中的环状肽end =“lead”→>环(Xaa-Arg- Pro-Ala-Lys)(I)<?in-line-formula description =“In-line Formulas”end =“tail”?>其中Xaa是Ala,Gly,Glu,Gln,Asp,Asn,Arg或Lys。 环肽具有溶栓作用。 本发明还涉及环肽制剂。
-
-